Načítá se...
Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
OBJECTIVE: The clinical course of multiple sclerosis (MS) is variable and largely unpredictable pointing to an urgent need for markers to monitor disease activity and progression. Recent evidence revealed that tissue transglutaminase (TG2) is altered in patient-derived monocytes. We hypothesize that...
Uloženo v:
| Vydáno v: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8105890/ https://ncbi.nlm.nih.gov/pubmed/33906937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000998 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|